uracil has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Illán-Cabeza, NA | 1 |
| Jiménez-Pulido, SB | 1 |
| Hueso-Ureña, F | 1 |
| Ramírez-Expósito, MJ | 1 |
| Sánchez-Sánchez, P | 1 |
| Martínez-Martos, JM | 1 |
| Moreno-Carretero, MN | 1 |
| Fushimi, K | 1 |
| Tanabe, N | 1 |
| Takami, M | 1 |
2 other studies available for uracil and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Effects on estrogen-dependent and triple negative breast cancer cells growth of Ni(II), Zn(II) and Cd(II) complexes with the Schiff base derived from pyridine-2-carboxaldehyde and 5,6-diamino-1,3-dimethyluracil explored through the renin-angiotensin syste
Topics: Aldehydes; Aminopeptidases; Breast Neoplasms; Cadmium; Cell Line, Tumor; Cell Proliferation; Crystal | 2018 |
[A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamid | 2014 |